Fresenius Medical Care Akcija

Fresenius Medical Care AAQS 2024

Fresenius Medical Care AAQS

3

Тикер

FME.DE

ISIN

DE0005785802

WKN

578580

Fresenius Medical Care ima trenutni AAQS od 3. Visok AAQS može se smatrati pozitivnim pokazateljem da se preduzeće uspešno razvija. Investitori mogu očekivati da je kompanija na dobrom putu da ostvari dobit. S druge strane, važno je posmatrati AAQS deonice Fresenius Medical Care u poređenju sa ostvarenom dobiti i drugim preduzećima iste branše. Visok AAQS nije apsolutna garancija za pozitivnu budućnost. Samo tako se može dobiti kompletna slika o performansama kompanije. Da bi se bolje procenio razvoj preduzeća, važno je posmatrati AAQS u poređenju sa drugim kompanijama iste branše. Generalno, investitori bi uvek trebali da posmatraju AAQS kompanije u kontekstu sa drugim finansijskim pokazateljima kao što su dobit, EBIT, Cash Flow i drugi, kako bi doneli obrazovane odluke o investiranju.

Fresenius Medical Care Aktienanalyse

Šta radi Fresenius Medical Care?

Fresenius Medical Care AG is a globally leading company in the field of dialysis and kidney care. The company was founded in 1996 when Fresenius AG merged its dialysis business with the US company National Medical Care (NMC). Today, Fresenius Medical Care operates in over 120 countries and employs around 120,000 people. The company operates more than 3,900 dialysis centers worldwide and serves approximately 345,000 dialysis patients. The business model of Fresenius Medical Care aims to improve the lives of patients with chronic kidney diseases by offering high-quality dialysis treatments, kidney care products, and treatment technologies. Fresenius Medical Care provides its patients with a comprehensive range of products and services that range from diagnosis to treatment and enable individualized patient care. A core competency of Fresenius Medical Care is the development and manufacture of dialysis products and technologies. The company offers a wide range of dialysis machines and accessories that can be used to support dialysis care in hospitals, clinics, and dialysis centers. In addition, the company offers medical solutions tailored to the needs of dialysis patients, including artificial kidneys, dialysis filters, and other medical devices. Fresenius Medical Care also conducts extensive research and development activities to develop innovative technologies as well as products and services that can improve the lives of dialysis patients. In terms of diagnostic products, Fresenius Medical Care offers a variety of laboratory and testing solutions that are used to monitor dialysis patients and ensure timely diagnosis of complications and infections. The company also offers a comprehensive range of medical devices and accessories that can be used to support patients in home dialysis. Fresenius Medical Care operates in three business segments: dialysis products, dialysis services, and hospital products. In the dialysis products segment, the company is engaged in the development, manufacture, and distribution of dialysis machines and accessories. In the dialysis services segment, the company operates a variety of dialysis centers and provides dialysis treatments performed by a multidisciplinary team of professionals. The company also operates a network of laboratories that offer diagnostic solutions for dialysis patients. In the hospital products segment, Fresenius Medical Care offers a variety of medical devices and solutions that help improve the clinical care of patients, including apheresis systems, infusion systems, and patient monitors. Throughout its history, Fresenius Medical Care has received numerous awards and recognitions, including the Innovation Award of the state of Baden-Württemberg for the development of an automated dialysis machine that enables better treatment of dialysis patients through the combination of online monitoring systems and intelligent algorithms. Overall, Fresenius Medical Care AG offers a comprehensive range of products and services for dialysis patients and is a significant player in the field of kidney care. The company is committed to improving the quality of life for patients with chronic kidney diseases and driving the development of innovative technologies and methods to treat this disease. Fresenius Medical Care ist eines der beliebtesten Unternehmen auf Eulerpool.com.

Fresenius Medical Care Продаја по сегменту

  • 70 % North America

  • 15 % EMEA

  • 11 % Asia-Pacific

  • 4 % Latin America

Često postavljana pitanja o Fresenius Medical Care akciji

Plansovi za štednju u akcijama nude atraktivnu mogućnost za investitore da dugoročno izgrade bogatstvo. Jedna od glavnih prednosti je takozvani efekat prosečne cene: investiranjem redovnog fiksnog iznosa u akcije ili fondove akcija, automatski se kupuju više deonica kada su cene niske i manje kada su visoke. To može dovesti do povoljnijeg prosečnog cena po deonici tokom vremena. Pored toga, plansovi za štednju u akcijama omogućuju čak i malim ulagačima pristup skupim akcijama, pošto je moguće učestvovati već sa malim iznosima. Redovno investiranje takođe podstiče disciplinovanu strategiju ulaganja i pomaže da se izbegnu emocionalne odluke, kao što su impulsivno kupovanje ili prodaja. Osim toga, investitori profitiraju od potencijalnog povećanja vrednosti akcija kao i od isplata dividendi, koje se mogu reinvestirati, što pojačava efekat kamate na kamatu i time rast investiranog kapitala.

Akcija Fresenius Medical Care je dostupna za štedne planove kod sledećih provajdera: Trade Republic, ING, Scalable Capital i Consorsbank

Andere Kennzahlen von Fresenius Medical Care

Naša analiza akcija za akciju Fresenius Medical Care Promet uključuje važne finansijske pokazatelje kao što su prihod, profit, P/E odnos, P/S odnos, EBIT, kao i informacije o dividendama. Takođe, razmatramo aspekte poput akcija, tržišne kapitalizacije, dugova, kapitala i obaveza kompanije Fresenius Medical Care Promet. Ako tražite detaljnije informacije o ovim temama, na našim podstranicama vam nudimo opsežne analize: